Twelve hour overnight oesophageal pH monitoring in patients with reflux symptoms.

Por Boesby, S, Wallin, L, Myrhøj, T, Andersen, L I
Publicado em 1991

A common BRCA1 mutation in Norwegian breast and ovarian cancer families?

Por Andersen, T. I., Børresen, A. L., Møller, P.
Publicado em 1996

Prognostic significance of TP53 alterations in breast carcinoma.

Por Andersen, T. I., Holm, R., Nesland, J. M., Heimdal, K. R., Ottestad, L., Børresen, A. L.
Publicado em 1993

Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.

Por Frebourg, T, Kassel, J, Lam, K T, Gryka, M A, Barbier, N, Andersen, T I, Børresen, A L, Friend, S H
Publicado em 1992

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family histor...

Por Børresen, A. L., Ottestad, L., Gaustad, A., Andersen, T. I., Heikkilä, R., Jahnsen, T., Tveit, K. M., Nesland, J. M.
Publicado em 1990

Screening breast cancer patients for Norwegian ATM mutations

Por Laake, K, Vu, P, Andersen, T I, Erikstein, B, Kåresen, R, Lønning, P E, Skovlund, E, Børresen-Dale, A L
Publicado em 2000

Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.

Por Børresen, A L, Hovig, E, Smith-Sørensen, B, Malkin, D, Lystad, S, Andersen, T I, Nesland, J M, Isselbacher, K J, Friend, S H
Publicado em 1991

Genome scanning of breast cancers by two-dimensional DNA typing.

Por Verwest, A. M., de Leeuw, W. J., Molijn, A. C., Andersen, T. I., Börresen, A. L., Mullaart, E., Uitterlinden, A. G., Vijg, J.
Publicado em 1994

Hypoxia enhances the wound-healing potential of adipose-derived stem cells in a novel human primary keratinocyte-based scratch assay

Por Riis, Simone, Newman, Rhonda, Ipek, Hilal, Andersen, Jens I., Kuninger, David, Boucher, Shayne, Vemuri, Mohan C., Pennisi, Cristian P., Zachar, Vladimir, Fink, Trine
Publicado no Int J Mol Med (2017)